Megastar Foods
- Market cap
- ₹ 288 Cr.
- P/E
- 30.8x
- P/B
- 2.91x
- 52-week range
- 204.4 – 392
- ROE
- 9%
- ROCE
- 12%
- Dividend yield
- 0%
- Debt / equity
- 1.28
- Sector
- Food Products
- Industry
- Other Food Products
- Listed on
- NSE, BSE
About
Megastar Foods Limited is an India-based producer and supplier of wheat flour, organic wheat flour and allied products. It operates in one segment: manufacturing and sale of wheat and its products. The Company is primarily engaged in the manufacturing of food-based products such as wheat flour and allied flour products, such as refined flour (Maida), Semolina (Suji) and Bran, among others. It has a wheat processing plant in Punjab, India, with an installed capacity of approximately 100000 metric tons (MT). It is catering to multinational companies (MNC’s) in India and exporting its products to The United Nations Organization, Europe, United States, and the Middle East. The Company has a wholly owned subsidiary (100%) namely Megapacific Ventures Pvt. Ltd.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Other Food Products: 42 companies →Megastar Foods against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)30.8 against a typical 19.1: pricier than most peers (1st = cheapest).28th of 41
- Sales growth+23.5% against a typical +23.5% from a year earlier.13th of 25
- Profit growth+37.7% against a typical +29.7% from a year earlier.9th of 22
- Share price, 3 months−16.8% against a typical −6.1%.35th of 40
- Size₹ 288 Cr. market value against a typical ₹ 118.1 Cr. (1st = largest).12th of 39
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Moderate safety, with caution
Rated BBB- by CARE- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | CARE BBB- / CARE A3 (Rating Watch with Negative Implications) | — | 23 Apr 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 23 Apr 2026 | Reaffirmed | CARE BBB- / CARE A3 → CARE BBB- / CARE A3 (Rating Watch with Negative Implications) | — | CARE | ₹ 300 Cr. | |
| 20 Mar 2026 | Reaffirmed | CARE BBB- / CARE A3 | — | CARE | ₹ 300 Cr. | |
| 31 Dec 2025 | ▲ Upgrade | CARE BBB- / CARE A3 | — | CARE | ₹ 241 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 2 Nov 2026Upcoming | Financial Results | For Consideration and Approval of Un-Audited Standalone and Consolidated Financial Results of The Company for the Quarter (Q2) and Half Year Ended September 30, 2026. |
| 12 Aug 2026 | Financial Results/Other business matters | Board Meeting Intimation to Consider and Approve, Inter Alia, The Un-Audited Financial Results (Standalone and Consolidated) For the Quarter Ended June 30, 2026 |
| 21 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 5 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 10 Nov 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2025 and other business matters |
| 6 Aug 2025 | Financial Results/Other business matters | To consider and approve the Standalone and Consolidated Un-audited financial results for the Quarter (Q1) ended June 30, 2025 and other business matters |
| 23 May 2025 | Financial Results/Other business matters | To consider and approve the Audited financial results (Standalone and Consolidated) for the period ended March 31, 2025 and other business matters |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 62 | 73 | 63 | 57 | 90 | 89 | 120 | 107 | 138 | 141 | 146 | 133 |
| Expenses | 58 | 69 | 60 | 55 | 85 | 83 | 110 | 101 | 129 | 132 | 136 | 125 |
| Operating Profit | 4 | 4 | 2 | 2 | 5 | 6 | 10 | 7 | 9 | 9 | 10 | 7 |
| OPM % | 5.7% | 5.2% | 3.7% | 3.4% | 5% | 6.7% | 8.1% | 6.3% | 6.7% | 6.7% | 6.8% | 5.6% |
| Other Income | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 2 | 1 | 1 | 2 | 4 | 6 | 2 | 4 | 4 | 5 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 3 | 2 | 1 | 1 | 2 | 1 | 2 | 2 | 3 | 4 | 3 | 3 |
| Tax % | 25.5% | 17.9% | 22.5% | 22.6% | 24.4% | 27.3% | 32.7% | 23.6% | 32% | 17.7% | 27.2% | 26.9% |
| Net Profit | 2 | 1 | 1 | 0 | 2 | 0 | 1 | 2 | 2 | 3 | 2 | 2 |
| EPS in Rs | 2.02 | 1.33 | 0.75 | 0.42 | 1.42 | 0.43 | 1.2 | 1.43 | 2.07 | 2.72 | 1.92 | 1.97 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 21%
- 5 Years
- 27%
- 3 Years
- 26%
- TTM
- 37%
- 10 Years
- 32%
- 5 Years
- 17%
- 3 Years
- −2%
- TTM
- 94%
- 10 Years
- —
- 5 Years
- 48%
- 3 Years
- 5%
- TTM
- —
- 10 Years
- 11%
- 5 Years
- 10%
- 3 Years
- 7%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Megastar Foods | ₹ 273.87 | ₹ 288 Cr. | 30.8x | 2.9x | 9% | — |
| Nestle India | ₹ 1,173.45 | ₹ 2,26,278 Cr. | 80.4x | 53.4x | 76.3% | 15.1% |
| Britannia Industries | ₹ 4,547.80 | ₹ 1,09,542 Cr. | 51.5x | 25.5x | 53.6% | 13.3% |
| Tata Consumer Products | ₹ 960.00 | ₹ 95,010 Cr. | 67.4x | 4.9x | 7.4% | 8.1% |
| Godrej Industries | ₹ 918.00 | ₹ 30,884 Cr. | 34.9x | 4x | 11.6% | 10.9% |
| Patanjali Foods | ₹ 351.00 | ₹ 38,193 Cr. | 18.9x | 2.8x | 14.8% | 4.5% |
Management
- Vikas Goel
- Managing Director, Executive Chairman of the Board
- Manisha Gupta
- Chief Financial Officer
- Harsh Sharma
- Compliance Officer, Company Secretary
- Mudit Goyal
- Whole Time Director
- Vikas Gupta
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.